Ipsen S.A.

Status: Publicly traded

Direct answer

Ipsen S.A. is publicly traded on PAR under the ticker IPN.PA.

Ipsen S.A. is an international biopharmaceutical enterprise, founded in 1929 and based in Boulogne-Billancourt, France. The company is dedicated to discovering, developing, and marketing innovative medicines globally, focusing on several key therapeutic areas: oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. Its extensive product lineup includes Somatuline, prescribed for...

Can you invest in Ipsen S.A.?

Yes. Ipsen S.A. trades publicly on PAR as IPN.PA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Ipsen S.A.

Detailed equity research is provided by MarketSnap.